Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$28.50
0.130.46%
At close: -
$28.50
0.000.00%
After Hours: 4:24 PM EDT
Comments
Loading...
Amphastar Pharma Analyst Ratings and Price Targets | NASDAQ:AMPH | Benzinga
Amphastar Pharmaceuticals Inc has a consensus price target of $52.57 based on the ratings of 8 analysts. The high is $70 issued by Jefferies on July 25, 2023. The low is $32 issued by Piper Sandler on March 21, 2025. The 3 most-recent analyst ratings were released by Piper Sandler, Piper Sandler, and Wells Fargo on March 21, 2025, February 4, 2025, and November 22, 2024, respectively. With an average price target of $41 between Piper Sandler, Piper Sandler, and Wells Fargo, there's an implied 43.86% upside for Amphastar Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Wells Fargo
JP Morgan
B of A Securities
Jefferies
1calculated from analyst ratings
Analyst Ratings for Amphastar Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | Buy Now | 12.28% | Piper Sandler | David Amsellem69% | $36 → $32 | Maintains | Neutral | Get Alert |
| 02/04/2025 | Buy Now | 26.32% | Piper Sandler | David Amsellem69% | $66 → $36 | Downgrade | Overweight → Neutral | Get Alert |
| 11/22/2024 | Buy Now | 92.98% | Wells Fargo | Joe Quatrochi37% | → $55 | Initiates | → Overweight | Get Alert |
| 08/08/2024 | Buy Now | 131.58% | Piper Sandler | David Amsellem69% | $71 → $66 | Maintains | Overweight | Get Alert |
| 08/08/2024 | Buy Now | — | Needham | Serge Belanger68% | — | Reiterates | → Hold | Get Alert |
| 06/27/2024 | Buy Now | 149.12% | Piper Sandler | David Amsellem69% | $71 → $71 | Reiterates | Overweight → Overweight | Get Alert |
| 05/22/2024 | Buy Now | — | Needham | Serge Belanger68% | — | Reiterates | → Hold | Get Alert |
| 05/09/2024 | Buy Now | — | Needham | Serge Belanger68% | — | Reiterates | → Hold | Get Alert |
| 04/10/2024 | Buy Now | — | Needham | Serge Belanger68% | — | Reiterates | → Hold | Get Alert |
| 03/05/2024 | Buy Now | 110.53% | JP Morgan | Ekaterina Knyazkova27% | → $60 | Initiates | → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 121.05% | B of A Securities | Jason Gerberry62% | → $63 | Initiates | → Neutral | Get Alert |
| 07/25/2023 | Buy Now | 145.61% | Jefferies | Glen Santangelo50% | → $70 | Reinstates | Buy → Buy | Get Alert |
| 05/17/2023 | Buy Now | 54.39% | Wells Fargo | Jacob Hughes52% | $40 → $44 | Maintains | Equal-Weight | Get Alert |
| 10/25/2022 | Buy Now | 40.35% | Piper Sandler | David Amsellem69% | $43 → $40 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | 26.32% | Jefferies | Glen Santangelo50% | → $36 | Assumes | → Buy | Get Alert |
| 07/29/2022 | Buy Now | 54.39% | Capital One | Tim Chiang37% | → $44 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Amphastar Pharma (AMPH) stock?
The latest price target for Amphastar Pharma (NASDAQ:AMPH) was reported by Piper Sandler on March 21, 2025. The analyst firm set a price target for $32.00 expecting AMPH to rise to within 12 months (a possible 12.28% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amphastar Pharma (AMPH)?
The latest analyst rating for Amphastar Pharma (NASDAQ:AMPH) was provided by Piper Sandler, and Amphastar Pharma maintained their neutral rating.
When was the last upgrade for Amphastar Pharma (AMPH)?
There is no last upgrade for Amphastar Pharma
When was the last downgrade for Amphastar Pharma (AMPH)?
The last downgrade for Amphastar Pharmaceuticals Inc happened on February 4, 2025 when Piper Sandler changed their price target from $66 to $36 for Amphastar Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Amphastar Pharma (AMPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amphastar Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amphastar Pharma was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
Is the Analyst Rating Amphastar Pharma (AMPH) correct?
While ratings are subjective and will change, the latest Amphastar Pharma (AMPH) rating was a maintained with a price target of $36.00 to $32.00. The current price Amphastar Pharma (AMPH) is trading at is $28.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.